Phase IV study evaluating talazoparib in patients with locally advanced or metastatic negative HER2 breast cancer and a somatic or germline BRCA1/2 mutation (ViTAL) - Analysis of cohort 1 according to hormonal receptor statusDelphine Loirat,Marie Duboys de la Barre,Jean-Christophe Thery, Ioana Hrab,Christelle Jouannaud, Jean-Loup Mouysset, Laura Salabert,Pauline Soibinet,Audrey Mailliez, Romain Valery, Anne Creisson,Cristian Villanueva,Nadine Dohollou,Jean-David Fumet,Thomas Grellety, Nathalie Perez-staub, Emma Lachaier,Aurore Iltis-roux, Miguel Delbado,Abeer Najem,Romuald Le Scodan,Elsa Curtit, Kais Aldabbagh,Pascal Pujol,Thibault de la Motte RougeCANCER RESEARCH(2023)引用 0|浏览13暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要